14-23061566-C-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001386863.1(ACIN1):c.3156G>T(p.Glu1052Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000509 in 1,571,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001386863.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACIN1 | NM_001386863.1 | c.3156G>T | p.Glu1052Asp | missense_variant | 17/19 | ENST00000605057.6 | NP_001373792.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACIN1 | ENST00000605057.6 | c.3156G>T | p.Glu1052Asp | missense_variant | 17/19 | 1 | NM_001386863.1 | ENSP00000474349.1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152062Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.00000566 AC: 1AN: 176660Hom.: 0 AF XY: 0.0000104 AC XY: 1AN XY: 95858
GnomAD4 exome AF: 0.00000141 AC: 2AN: 1419580Hom.: 0 Cov.: 35 AF XY: 0.00000142 AC XY: 1AN XY: 702274
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152062Hom.: 0 Cov.: 30 AF XY: 0.0000269 AC XY: 2AN XY: 74270
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2023 | The c.3330G>T (p.E1110D) alteration is located in exon 17 (coding exon 17) of the ACIN1 gene. This alteration results from a G to T substitution at nucleotide position 3330, causing the glutamic acid (E) at amino acid position 1110 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at